Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
News headline image
Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
News headline image
SRAD SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via GlobeNewswire
Tickers SRAD
News headline image
DIRTT to Announce First Quarter 2026 Financial Results on May 7, 2026
From DIRTT Environmental Solutions
Via GlobeNewswire
Tickers DRTTF TSX:DRT
News headline image
Qfin Holdings Filed 2025 Annual Report on Form 20-F
From Qfin Holdings, Inc.
Via GlobeNewswire
Tickers QFIN
News headline image
New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation
From MediciNova, Inc.
Via GlobeNewswire
Tickers MNOV
News headline image
Churchill Capital Corp XII Announces the Pricing of Upsized $360 Million Initial Public Offering
From Churchill Capital Corp XII
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers MEDP
News headline image
MINILUXE REPORTS FULL-YEAR FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 28, 2025
From MiniLuxe Holding Corp.
Via GlobeNewswire
Tickers MNLXF TSX-V:MNLX
News headline image
Five Star Bancorp Announces First Quarter 2026 Results
From Five Star Bank
Via GlobeNewswire
Tickers FSBC
News headline image
NEKTAR THERAPEUTICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Nektar Therapeutics and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers NKTR
News headline image
Anuma launches private AI with one memory across every leading model
From Anuma
Via GlobeNewswire
News headline image
Rubicon Organics to Report Q1 2026 Results; Announces Line of Credit Amendment
From Rubicon Organics
Via GlobeNewswire
Tickers ROMJF TSX-V:ROMJ
News headline image
Bragar Eagel & Squire, P.C. Urges Soleno Therapeutics, Inc. Investors with Significant Losses to Contact the Firm Before May 5th Lead Plaintiff Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers SLNO
News headline image
Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment
From Biomea Fusion, Inc.
Via GlobeNewswire
Tickers BMEA
News headline image
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
Tickers HRTX
News headline image
Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting
From Taysha Gene Therapies, Inc.
Via GlobeNewswire
Tickers TSHA
News headline image
Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults
From Crinetics Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers CRNX
News headline image
Brown & Brown, Inc. announces first quarter 2026 results, including total revenues of $1.9 billion, an increase of 35.4%; flat Organic Revenue; growth of Organic Revenue with Contingents of 2.2%; diluted net income per share of $1.06; Diluted Net Income
From Brown & Brown, Inc.
Via GlobeNewswire
Tickers BRO
News headline image
ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
From ElevateBio
Via GlobeNewswire
News headline image
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Seven Goranson Bain Ausley Attorneys Named to D Magazine’s 2026 Best Lawyers in Dallas
From Goranson Bain Ausley
Via GlobeNewswire
News headline image
North American Construction Group Ltd. First Quarter Results Conference Call and Webcast Notification
From North American Construction Group Ltd.
Via GlobeNewswire
Tickers NOA TSX:NOA
News headline image
BABCOCK & WILCOX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Babcock & Wilcox Enterprises, Inc. Investors with Large Losses to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers BW
News headline image
Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Tickers DYN
News headline image
Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences
From Editas Medicine, Inc.
Via GlobeNewswire
Tickers EDIT
News headline image
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
From Sana Biotechnology, Inc
Via GlobeNewswire
Tickers SANA
News headline image
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
News headline image
Robin Energy Announces Final Results of Tender Offer for Common Shares
From Robin Energy Ltd.
Via GlobeNewswire
Tickers RBNE
News headline image
Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
From Charlton Aria Acquisition Corp
Via GlobeNewswire
Tickers CHARR CHARU
News headline image
Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting
From Cellectis Inc.
Via GlobeNewswire
Tickers CLLS
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.